BETTELLI, Stefania Raffaella
 Distribuzione geografica
Continente #
NA - Nord America 5.621
EU - Europa 2.691
AS - Asia 994
AF - Africa 10
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 4
Totale 9.336
Nazione #
US - Stati Uniti d'America 5.587
GB - Regno Unito 834
IT - Italia 522
SE - Svezia 313
CN - Cina 302
DE - Germania 292
IE - Irlanda 281
SG - Singapore 233
HK - Hong Kong 144
UA - Ucraina 139
TR - Turchia 105
FI - Finlandia 88
BG - Bulgaria 56
JP - Giappone 51
FR - Francia 47
IN - India 45
CA - Canada 34
VN - Vietnam 25
BE - Belgio 22
ID - Indonesia 21
PK - Pakistan 17
LT - Lituania 13
MY - Malesia 13
CZ - Repubblica Ceca 12
NL - Olanda 12
IR - Iran 10
PL - Polonia 10
RU - Federazione Russa 9
CH - Svizzera 6
DK - Danimarca 6
KR - Corea 6
RO - Romania 6
TW - Taiwan 6
EU - Europa 5
GR - Grecia 5
BR - Brasile 4
NO - Norvegia 4
TH - Thailandia 4
TZ - Tanzania 4
AU - Australia 3
IQ - Iraq 3
AR - Argentina 2
AT - Austria 2
BO - Bolivia 2
CL - Cile 2
EG - Egitto 2
IL - Israele 2
MK - Macedonia 2
PH - Filippine 2
PT - Portogallo 2
SI - Slovenia 2
UG - Uganda 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
BD - Bangladesh 1
ES - Italia 1
HU - Ungheria 1
KE - Kenya 1
LB - Libano 1
MA - Marocco 1
ME - Montenegro 1
MT - Malta 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 9.336
Città #
Fairfield 817
Southend 660
Chandler 497
Woodbridge 437
Ashburn 389
Houston 345
Seattle 341
Santa Clara 316
Ann Arbor 294
Cambridge 284
Dublin 280
Jacksonville 261
Dearborn 260
Wilmington 254
Nyköping 226
Singapore 204
Hong Kong 137
Modena 103
Beijing 92
New York 86
Izmir 68
Princeton 60
San Diego 58
Sofia 56
Helsinki 55
Eugene 50
Tokyo 46
Milan 34
Bologna 33
Fremont 32
London 32
Falls Church 31
Shanghai 31
Bremen 24
Dong Ket 23
Munich 23
Jakarta 21
Ottawa 21
Brussels 18
Rome 18
Redwood City 17
Norwalk 16
Lahore 15
Parma 13
Brno 11
Lansdale 11
Los Angeles 11
Grafing 9
Kunming 9
Nanjing 9
San Giuliano Milanese 9
Boardman 8
Frankfurt am Main 8
Padova 8
Reggio Emilia 8
Calcinaia 7
Castelnuovo Berardenga 7
Charleston 7
Des Moines 7
Kielce 7
Sassuolo 7
Berlin 6
Hefei 6
Hyderabad 6
San Mateo 6
Tulare 6
Venezia 6
Bangalore 5
Kilburn 5
Leicester 5
Mumbai 5
Nanchang 5
Phoenix 5
Shenyang 5
Taipei 5
Vernon 5
Ardabil 4
Athens 4
Chicago 4
Florence 4
Harbin 4
Islington 4
Lavello 4
Lüleburgaz 4
Naples 4
Novate Milanese 4
Rimini 4
San Francisco 4
San Marco 4
Suwon 4
Toronto 4
Verona 4
Acton 3
Augusta 3
Bangkok 3
Bronx 3
Castelvetrano 3
Chengdu 3
Chongqing 3
Dallas 3
Totale 7.390
Nome #
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management 292
Assessment of freezing effects and diagnostic potential of BioBank healthy and neoplastic breast tissues through HR-MAS NMR spectroscopy 262
Poorly differentiated clusters (PDC) in colorectal cancer: What is and ought to be known. 252
Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus 228
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status. 223
Quick assessment of cell-free DNA in seminal fluid and fragment size for early non-invasive prostate cancer diagnosis 223
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 213
Prospective biomarker analysis of the randomized CHER-LOB study evaluating the dual anti-HER2 treatment with trastuzumab and lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive breast cancer 203
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. 200
Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer.. 198
Prediction of distant recurrence in resected stage I and II lung adenocarcinoma 198
Molecular Profile, as detected with Mass-Array Spectrometry (Sequenom platform), in primary and metastatic breast carcinoma treated with Exemestane + Everolimus 197
Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients. 196
Clinical and molecular analysis of long-term HER2 positive metastatic breast cancer survivors. 195
Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer 195
Cytomegalovirus infection of the upper gastrointestinal tract: a clinical and pathological study of 30 cases. 192
Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients 190
Alveolar rhabdomyosarcoma of the uterine cervix. A case report confirmed by FKHR break-apart rearrangement using a fluorescence in situ hybridization probe on paraffin-embedded tissues. 186
Atypical Spitzoid melanocytic tumors:A morphological, mutational, and FISH analysis 185
Overall survival in patients with lung adenocarcinoma harboring "niche" mutations: an observational study 185
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single Institution analysis 182
Alterations of 9p21 analysed by FISH and MLPA distinguish atypical spitzoid melanocytic tumours from conventional Spitz's nevi but do not predict their biological behaviour. 176
Durable remission in a patient with leptomeningeal relapse of a MYC/BCL6-positive double-hit DLBCL treated with lenalidomide monotherapy 176
ASSESSMENT OF FREEZING EFFECTS AND DIAGNOSTIC POTENTIAL OF BIOBANK HEALTHY AND NEOPLASTIC BREAST TISSUES THROUGH HR-MAS NMR SPECTROSCOPY 176
Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy. 175
Does HPV play a role in the etiopathogenesis of ameloblastoma? An immunohistochemical, in situ hybridization and polymerase chain reaction study of 18 cases using laser capture microdissection 174
Cerebrospinal fluid cytology in a case of primary diffuse leptomeningeal and pineal melanocytic lesion, with histological confirmation 173
Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status 172
Analysis of KRAS, NRAS, PIK3CA, and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer 172
Molecular profile in primary and metastatic breast cancer treated with Exemestane and Everolimus. 162
Expression of estrogen receptor in hemangioma of the uterine cervix: Reports of three cases and review of the literature 161
Preoperative letrozole plus lapatinib/placebo for HR+/HER2 negative operable breast cancer: biomarker analyses of the randomized phase II LET-LOB study 159
Proteomics Analysis of Formalin-Fixed Paraffine-Embedded Tissue Reveals Key Proteins Related to Lung Dysfunction in Idiopathic Pulmonary Fibrosis. 158
EGFR polysomy in squamous cell carcinoma of the thyroid. Report of two cases and review of the literature 158
Prognostic impact of estrogen receptor (ER) level changes during progression for patients with both ER-positive (ER+) primary breast cancer and paired recurrence 150
The prognostic role of c-kit protein expression in resected large cell neuroendocrine carcinoma of the lung. 149
Microsatellite and EGFR, HER2 and K-RAS analyses in sclerosing hemangioma of the lung 149
Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status. 146
Clinical impact and prognostic role of KRAS/BRAF/PIK3CA mutations in stage I colorectal cancer 143
Trans-CHER-Lob: A Biomarker Analysis of the Randomized Phase II Study of Neoadjuvant Chemotherapy Plus Trastuzumab, Lapatinib or Combined Trastuzumab and Lapatinib in HER2 Positive Operable Breast Cancer. 137
Prediction of Distant Recurrence-Free Survival in Resectable Lung Adenocarcinoma. 137
High-Resolution Melting is a sensitive, cost-effective, time-saving technique for BRAF V600E detection in thyroid FNAB washing fluid: a prospective cohort study 136
Change in HER2 Status in HER2 Positive Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without Anti-HER2 Therapy: Analysis of Two Consecutive Cohorts 136
Detection of human papillomavirus DNA in urinary bladder carcinoma by in situ hybridization 128
FISH analysis in cell touch preparations and cytological specimens from formalin-fixed fetal autopsies. 127
KRAS, NRAS, BRAF mutations and high counts of poorly differentiated clusters of neoplastic cells in colorectal cancer: Observational analysis of 175 cases 123
Evaluation of the effects of cryopreservation on Modena Biobank tissue samples through HR-MAS NMR 115
Prognostic role of HER2 loss after neoadjuvant therapy in patients with HER2-positive operable breast cancer 114
COMPARISON OF HER-2 STATUS IN PRIMARY BREAST CANCER AND METASTATIC SITES: RESULTS FROM A SINGLE INSTITUTION ANALYSIS 112
Correlation between CD133 expression and mgmt status in recurrences melanoma 110
35. PREDICTORS OF HER2 FISH POSITIVITY IN PRIMARY BREAST CANCER DIAGNOSIS SCORED 2+ WITH IHC: RESULTS OF A SINGLE INSTITUTION ANALYSIS 108
Predictors of HER2 gene amplification in immunohistochemistry score 2+ Early Breast Cancer according to 2018 ASCO/CAP guidelines: a single institution analysis. 100
Cell of origin (COO), BCL2/MYC status and IPI define a group of patients with Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis in a real-world clinical setting 96
Morphological analysis of three extrathoracic bronchogenic cysts simulating neoplasms 94
Histopathological variables in liver metastases of patients with stage IV colorectal cancer: potential prognostic relevance of poorly differentiated clusters 86
Deepening the knowledge of ros1 rearrangements in non-small cell lung cancer: Diagnosis, treatment, resistance and concomitant alterations 75
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 63
Unexpected tumor response to palliative pelvic radiotherapy in mismatch repair-deficient advanced prostate cancer: a case report 62
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients 38
CtDNA-guided rechallenge with anti-EGFR therapy in RASwt metastatic colorectal cancer: Evidence from clinical practice 27
Clinicopathological, cytogenetic, and molecular profiles of primary cutaneous diffuse large B-cell lymphomas 16
Totale 9.464
Categoria #
all - tutte 39.197
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.197


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.441 0 0 0 0 191 265 332 206 230 56 105 56
2020/20211.642 147 88 135 183 223 89 103 182 103 173 114 102
2021/20221.179 52 128 94 71 40 91 54 58 121 123 202 145
2022/20231.520 149 164 117 122 121 178 35 115 400 13 46 60
2023/2024937 18 53 47 91 160 68 194 114 23 21 55 93
2024/2025761 77 30 78 217 359 0 0 0 0 0 0 0
Totale 9.464